Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pradere

Showing results (151-160 of 412) with videos related to

Pageof 42
Sort By:
Urologic Oncology|April 23, 2021
Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic reviewEkaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
Cancers|April 12, 2022
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate CancerMarcin Miszczyk, Justyna Rembak-Szynkiewicz, Łukasz Magrowski, et al.
Immunotherapy|September 11, 2023
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysisTakafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, et al.
World Journal of Urology|July 3, 2023
Same-day discharge for endoscopic enucleation of the prostate: a systematic review and meta-analysisPietro Diana, Michael Baboudjian, Alberto Saita, et al.
European Urology Oncology|January 7, 2022
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomyEkaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
European Urology Open Science|May 31, 2022
Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled AnalysisMichael Baboudjian, Daniel Moser, Takafumi Yanagisawa, et al.
European Urology Focus|May 13, 2022
Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial CarcinomaEkaterina Laukhtina, Melanie R Hassler, Benjamin Pradere, et al.
Urologic Oncology|October 11, 2021
Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancerGiovanni E Cacciamani, Richard S Matulewicz, Raj Kumar, et al.
International Journal of Clinical Oncology|January 27, 2021
Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysisZine-Eddine Khene, Gilles Dosin, Benoit Peyronnet, et al.
Nature Reviews. Urology|December 24, 2021
The placebo and nocebo effects in functional urologyHadi Mostafaei, Sandra Jilch, Greta Lisa Carlin, et al.
Pageof 42

Showing results (151-160 of 412) with videos related to

Sort By:
Pageof 42
Urologic Oncology|April 23, 2021
Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic reviewEkaterina Laukhtina, Benjamin Pradere, Keiichiro Mori, et al.
Cancers|April 12, 2022
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate CancerMarcin Miszczyk, Justyna Rembak-Szynkiewicz, Łukasz Magrowski, et al.
Immunotherapy|September 11, 2023
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysisTakafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, et al.
World Journal of Urology|July 3, 2023
Same-day discharge for endoscopic enucleation of the prostate: a systematic review and meta-analysisPietro Diana, Michael Baboudjian, Alberto Saita, et al.
European Urology Oncology|January 7, 2022
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomyEkaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
European Urology Open Science|May 31, 2022
Benefit and Harm of Active Surveillance for Biopsy-proven Renal Oncocytoma: A Systematic Review and Pooled AnalysisMichael Baboudjian, Daniel Moser, Takafumi Yanagisawa, et al.
European Urology Focus|May 13, 2022
Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial CarcinomaEkaterina Laukhtina, Melanie R Hassler, Benjamin Pradere, et al.
Urologic Oncology|October 11, 2021
Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancerGiovanni E Cacciamani, Richard S Matulewicz, Raj Kumar, et al.
International Journal of Clinical Oncology|January 27, 2021
Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysisZine-Eddine Khene, Gilles Dosin, Benoit Peyronnet, et al.
Nature Reviews. Urology|December 24, 2021
The placebo and nocebo effects in functional urologyHadi Mostafaei, Sandra Jilch, Greta Lisa Carlin, et al.
Pageof 42